Joint disease affects over 600 million people worldwide.
RheoCarti addresses this challenge with a next-generation joint implant that replicates the mechanics of natural cartilage—delivering ultra-low friction, intrinsic damping, and smoother, more natural movement.
RheoCarti, real movement for active patients.
RheoCarti is an ETH Zurich originated orthopedics venture in formation. The concept is being developed by an ETH researcher and professor with expertise in joint biomechanics and implant materials and design. RheoCarti aims to translate advanced cartilage-mimicking materials into next-generation hip resurfacing solutions for both veterinary and human applications.
Check our latest news
News |  |
07/08/2026, 09:57 PM
ETH Pioneer Fellowship
🎉 We are proud to announce that our founder, Dr. Xiaoyu Du, has been awarded an ETH Pioneer Fellowship! This prestigious fellowship will support the next stage of RheoCarti's journey as we advance our... More
04/02/2026, 01:30 PM
Venture Kick stage 2
RheoCarti was selected at Venture Kick's second financial and entrepreneurial support stage. 💰 Check out more at the following link:... More
02/04/2026, 04:24 PM
Innosuisse Startup Coaching program
RheoCarti has been supported by the Innosuisse Startup Coaching program, with Dr. Heiko Visarius guiding business development and Karina Candrian advising on regulatory strategy, strengthening RheoCarti’s... More
01/04/2026, 04:12 PM
Venture Kick stage 1
Medrich (our former project name) was selected at Venture Kick's first financial and entrepreneurial support stage. 💰 Check out more at the following... More
10/28/2025, 04:52 PM
Third prize at Shenzhen competition
Congrats! Medrich won third prize at the 9th China (Shenzhen) Innovation & Entrepreneurship International Competition (Zurich Switzerland Division). More
| Older >> |
Acknowledgement
